Ask to take part

Contact the study team using the details below to take part. If there are no contact details below please ask your doctor in the first instance.

Contact Information:

Mrs Sarah Rees
+44 (0)1554 899108
sarah.rees7@wales.nhs.uk


Study Location:

Find another location


Questions to ask
Skip to Main Content
English | Cymraeg
Be Part of Research - Trial Details - COPD Pal Phase 2: A self-management app for Chronic Obstructive Pulmonary Disease. A pilot study
Back

COPD Pal Phase 2: A self-management app for Chronic Obstructive Pulmonary Disease. A pilot study

Not Recruiting

Open to: All Genders

Age: Adult

Llanelli

Medical Conditions

Chronic obstructive pulmonary disease

This information is provided directly by researchers, and we recognise that it isn't always easy to understand. We are working with researchers to improve the accessibility of this information. In some summaries, you may come across links to external websites. These websites will have more information to help you better understand the study.


Chronic Obstructive Pulmonary Disease (COPD) is the name for a group of lung conditions that cause breathing difficulties. COPD is responsible for 3 million deaths worldwide every year. In the UK, the condition costs the NHS over ÂŁ500 million. Even though people with COPD need to use many healthcare services, they spend a very small amount of time (about 1%) of their time with a healthcare professional. The rest of the time, people with COPD need to self-manage their condition, which includes exercising, taking medication, and being aware of their symptoms. To encourage better self-management, Bond Digital Health have created a mobile phone app called COPD Pal that helps people with COPD keep track of their condition.

We have designed this study to help us to look at how people use COPD Pal and to look at how safe it is, so that we can design larger studies in the future.

Start dates may differ between countries and research sites. The research team are responsible for keeping the information up-to-date.  

The recruitment start and end dates are as follows:

20 Jan 2020 16 Feb 2020

Publications

2021 Results article in https://doi.org/10.1007/s12553-021-00534-w (added 11/11/2021)

Participants will be asked to use COPD Pal over 6 weeks. Participants will be asked to complete a questionnaire about self-management at the beginning and end of the study, we will record information about any COPD exacerbations they have had prior to and during the study and there will be a feedback form to fill in, asking questions about their experience of using COPD Pal.


Adults over 18 years with COPD

You can take part if:



You may not be able to take part if:


1. Cognitive, visual, or motor impairment that would affect ability to see or use a smart phone2. Current hospital inpatient or nursing home resident


Below are the locations for where you can take part in the trial. Please note that not all sites may be open.

  • Prince Philip Hospital
    Bryngwyn Mawr Dafen
    Llanelli
    SA14 8QF

Taking part in the study may help you with managing your COPD and associated symptoms. It will also help develop the app, which may help future patients.
There is no additional risk associated with participating in this study apart from the time needed to access the app. There is a small chance that you feel tired whilst using the app or completing the questionnaires. In which case, please take as many breaks as you need and take part at your own pace.

Mrs Sarah Rees
+44 (0)1554 899108
sarah.rees7@wales.nhs.uk



The study is sponsored by Hywel Dda University Health Board and funded by Llywodraeth Cymru.



We'd like your feedback

Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.


Is this study information helpful?

What will you do next?
Read full details for Trial ID: ISRCTN14530045
Last updated 20 September 2023

This page is to help you find out about a research study and if you may be able to take part

You can print or share the study information with your GP/healthcare provider or contact the research team directly.   

Back to the top